Belgian (BEL20) Growth Pharmaceuticals & Biotech Stocks
UPDATED Feb 07, 2026
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
HYL | €7.40 | -7.3% | 37.0% | €207.2m | €13.57 | 24.5 | 79.9% | n/a | ||
ARGX | €695.60 | -1.2% | 10.1% | €42.6b | €813.91 | 32.8 | 23.0% | n/a | ||
UCB | €262.00 | 2.6% | 38.4% | €49.8b | €273.16 | 37.4 | 19.3% | 0.5% | ||
OXUR | €0.007 | 2.9% | -97.1% | €490.7k | n/a | 0.3 | n/a | n/a | ||
BIOS | €0.0023 | -4.2% | -28.1% | €1.5m | n/a | -0.4 | n/a | n/a | ||
TUB | €225.00 | 4.9% | 47.3% | €10.0b | €230.50 | 108.0 | n/a | 0.5% | ||
ALEMS | €5.32 | 2.7% | -19.4% | €22.5m | n/a | 19.2 | n/a | n/a | ||
CYAD | €0.18 | 2.9% | -58.1% | €8.1m | n/a | 43.3 | n/a | n/a |
Page 1 of 1